Table 2.

The prevalence and incidence of BRONJ in osteoporosis patients in Asia.

Country	Study	Evaluated year	Prevalence	Estimated incidence rate
Japan	Yoneda et al. [46]	2006–2008		0.01%–0.02% 0.85/100,000 patient-years
Japana	Yoneda et al. [35]	2011–2013		40–50/100,000 patient-years
Korea	Lee et al. [49]	2008		0.04%
Korea	Hong et al. [48]	2008–2010		0.05%–0.07%
Hong Kong	Kwok et al. [38]	2002–2012	0.31%	73.53/100,000 patient-years
Taiwan	Lin et al. [50]	2003–2007		6.9–8.2/10,000 patient-years
Taiwan	Yuh et al. [39]	2006–2008		41.3/100,000 patient-years
Taiwan	Chiu et al. [51]	2000–2012		283/100,000 patient-years
Taiwan	Huang et al. [20]	2000–2010		11.72/10,000 patient-years

BRONJ, bisphosphonate-related osteonecrosis of the jaw.

^aIncidence was estimated by author of the current paper.